To evaluate the protein expressions of FOXO1 and PAX3 in EOC, we analyzed FOXO1 and PAX3 protein levels in 212 EOC tissues, 57 borderline tumors, 153 benign tumors, and 79 nonadjacent normal epithelial tissues by IHC. This evidence concerns the gene PAX3 and benign neoplasm.